Is MGM-15 Legal in Michigan? (2026)

Instrument

Substance designated as controlled under federal law; similar scheduling

Source

https://www.legislature.mi.gov/Laws/MCL?objectName=mcl-333-7204

Retrieved

2026-10-29

Fingerprint

8c642dd1d05eb7a8

333.7204 Substance designated, rescheduled, or deleted as controlled substance under federal law; notice; board meeting; similar schedule of substance by administrator; publication of reasons for determination.

Sec. 7204.

    
If a substance is designated, rescheduled, or deleted as a controlled substance under federal law and notice of that designation, rescheduling, or deletion is given to the administrator, the substance must be similarly scheduled under section 7201 unless the administrator holds a board meeting not more than 60 days after notice is received to determine whether the substance should be similarly controlled under section 7201. If the administrator decides not to similarly schedule the substance, the administrator shall, not more than 60 days after that decision is made, publish the reasons for that determination.

Instrument

Schedule 1; controlled substances included

Source

https://www.legislature.mi.gov/Laws/MCL?objectName=mcl-333-7212

Retrieved

2026-10-29

Fingerprint

c4ee9db4ae9aa4a9

333.7212 Schedule 1; controlled substances included.

Sec. 7212.

    
(1) The following controlled substances are included in schedule 1:

    
(a) Any of the following opiates, including their isomers, esters, the ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, when the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:

Acetylmethadol

Difenoxin

Noracymethadol

Allylprodine

Dimenoxadol

Norlevorphanol

Alpha-acetylmethadol

Dimepheptanol

Normethadone

Alphameprodine

Dimethylthiambutene

Norpipanone

Alphamethadol

Dioxaphetyl
  butyrate

Phenadoxone

Benzethidine

Dipipanone

Phenampromide

Betacetylmethadol

Ethylmethylthiambutene

Phenomorphan

Betameprodine

Etonitazene

Phenoperidine

Betamethadol

Etoxeridine

Piritramide

Betaprodine

Furethidine

Proheptazine

Clonitazene

Hydroxypethidine

Properidine

Dextromoramide

Ketobemidone

Propiram

Diampromide

Levomoramide

Racemoramide

Diethylthiambutene

Levophenacylmorphan

Trimeperidine

Morpheridine

(b) Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted, when the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

Acetorphine

Drotebanol

Morphine-N-Oxide

Acetyldihydrocodeine

Etorphine

Myrophine

Benzylmorphine

Heroin

Nicocodeine

Codeine
  methylbromide

Hydromorphinol

Nicomorphine

Codeine-N-Oxide

Methyldesorphine

Normorphine

Cyprenorphine

Methyldihydromorphine

Pholcodine

Desomorphine

Morphine
  methylbromide

Thebacon

Dihydromorphine

Morphine
  methylsulfonate

(c) Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, when the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designation:

2-Methylamino-1-phenylpropan-1-one

Some
  trade and other names:

Methcathinone

Cat

Ephedrone

3,
  4-methylenedioxy amphetamine

5-methoxy-3,
  4-methylenedioxy

amphetamine

3,
  4, 5-trimethoxy amphetamine

Bufotenine

Some
  trade and other names:

3-(B-dimethylaminoethyl)-5
  hydrozyindole

3-(2-dimethylaminoethyl)-5
  indolol

N,N-dimethylserotonin;
  5-hydroxy-N-dimethyltryptamine

Mappine

2,
  5-Dimethoxyamphetamine

Some
  trade or other names:

2, 5-Dimethoxy-a-methylphenethylamine;
  2,5-DMA

4-Bromo-2,
  5-Dimethoxyamphetamine

Some
  trade or other names:

4-bromo-2,
  5 dimethoxy-a-methylphenethylamine; 4-bromo

2,5-DMA

Diethyltryptamine

Some
  trade and other names:

N,N-Diethyltryptamine;
  DET

Dimethyltryptamine

Some
  trade or other names:

DMT

4-methyl-2,
  5-dimethoxyamphetamine

Some
  trade and other names:

4-methyl-2,
  5-dimethoxy-a-methyl-phenethylamine

DOM,
  STP

4-methoxyamphetamine

Some
  trade or other names:

4-methoxy-a-methylphenethylamine;
  paramethoxy amphetamine;

PMA

Ibogaine

Some
  trade and other names:

7-Ethyl-6,6a,7,8,9,10,12,13

Octahydro-2-methoxy-6,9-methano-5H-

pyrido
  (1, 2:1, 2 azepino 4, 5-b) indole

tabernanthe
  iboga

Lysergic
  acid diethylamide

Except
  as provided in subsection (2), Marihuana, including

pharmaceutical-grade
  cannabis

Mecloqualone

Mescaline

Peyote

N-ethyl-3
  piperidyl benzilate

N-methyl-3
  piperidyl benzilate

Psilocybin

Psilocyn

Thiophene
  analog of phencyclidine

Some
  trade or other names:

1-(1-(2-thienyl)cyclohexyl)
  piperidine

2-thienyl
  analog of phencyclidine; TPCP

(d) Synthetic equivalents of the substances contained in the plant, or in the resinous extractives of cannabis and synthetic substances, derivatives, and their isomers with similar chemical structure or pharmacological activity, or both, such as the following, are included in schedule 1:

    
(i) /\1 cis or trans tetrahydrocannabinol, and their optical isomers.

    
(ii) /\6 cis or trans tetrahydrocannabinol, and their optical isomers.

    
(iii) /\3,4, cis or trans tetrahydrocannabinol, and their optical isomers.

    
(e) Synthetic cannabinoids. As used in this subdivision, “synthetic cannabinoids” includes any material, compound, mixture, or preparation that is not otherwise listed as a controlled substance in this schedule or in schedules II through V, is not approved by the federal food and drug administration as a drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues (analogs), and salts of isomers and homologues (analogs), unless specifically excepted, whenever the existence of these salts, isomers, homologues (analogs), and salts of isomers and homologues (analogs) is possible within the specific chemical designation:

    
(i) Any compound containing a 3-(1-naphthoyl)indole structure, also known as napthoylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent. Examples of this structural class include but are not limited to: JWH-007, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-1220, AM-2201, and WIN-55, 212-2.

    
(ii) Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure, also known as napthylmethylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent. Examples of this structural class include but are not limited to: JWH-175, and JWH-184.

    
(iii) Any compound containing a 3-(1-naphthoyl)pyrrole structure, also known as naphthoylpyrroles with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2- piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent. Examples of this structural class include but are not limited to: JWH-370, JWH-030.

    
(iv) Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indene ring to any extent and whether or not substituted on the naphthyl ring to any extent. Examples of this structural class include but are not limited to: JWH-176.

    
(v) Any compound containing a 3-phenylacetylindole structure, also known as phenacetylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent. Examples of this structural class include but are not limited to: RCS-8 (SR-18), JWH-250, JWH-203, JWH-251, and JWH-302.

    
(vi) Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure, also known as cyclohexylphenols, with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted on the cyclohexyl ring to any extent. Examples of this structural class include but are not limited to: CP-47,497 (and homologues(analogs)), cannabicyclohexanol, and CP-55,940.

    
(vii) Any compound containing a 3-(benzoyl)indole structure, also known as benzoylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent. Examples of this structural class include but are not limited to: AM-694, pravadoline (WIN-48,098), RCS-4, AM-630, AM-679, AM-1241, and AM-2233.

    
(viii) Any compound containing a 11-hydroxy-/\8-tetrahydrocannabinol structure, also known as dibenzopyrans, with further substitution on the 3-pentyl group by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkyethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group. Examples of this structural class include but are not limited to: HU-210, JWH-051, JWH-133.

    
(ix) Any compound containing a 3-(L-adamantoyl)indole structure, also known as adamantoylindoles, with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted on the adamantyl ring system to any extent. Examples of this structural class include but are not limited to: AM-1248.

    
(x) Any other synthetic chemical compound that is a cannabinoid receptor agonist and mimics the pharmacological effect of naturally occurring cannabinoids that is not listed in schedules II through V and is not approved by the federal food and drug administration as a drug.

    
(f) Compounds of structures referred to in subdivision (d), regardless of numerical designation of atomic positions, are included.

    
(g) Gamma-hydroxybutyrate and any isomer, salt, or salt of isomer of gamma-hydroxybutyrate.

Some
  trade and other names:

Sodium
  oxybate

4-hydroxybutanoic
  acid monosodium salt

(h) 3,4-methylenedioxymethamphetamine.

Some
  trade and other names:

Ecstasy

MDMA

(i) N-Benzylpiperazine

Some
  trade and other names:

BZP

Benzylpiperazine

1-(phenylmethyl)-piperazine

(j) 3-Chlorophenylpiperazine

Some
  trade and other names:

MCPP

(k) 1-(3-Trifluoromethylphenyl)piperazine

Some
  trade and other names:

TFMPP

(l) 4-Bromo-2,5-dimethoxybenzylpiperazine

Some
  trade and other names:

2C-B-BZP

(m) All of the following:

    
(i) (6aR,10aR)-9-(Hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol.

Some
  trade and other names:

HU-210

(ii) 2-[(1R,3S)-3-hydroxycyclohexyl]-5-(2-methyloctan-2-yl)phenol and its side chain homologues.

Some
  trade and other names:

CP47,497

(iii) 1-pentyl-3-(1-naphthoyl)indole.

Some
  trade and other names:

JWH-018

(iv) 1-butyl-3-(1-naphthoyl)indole.

Some
  trade and other names:

JWH-073

(v) (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone.

Some
  trade and other names:

JWH-015

(vi) [1-[2-(4-morpholinyl)ethyl]-1H-indol-3-yl]-1-naphthalenyl-methanone.

Some
  trade and other names:

JWH-200

(vii) 1-(1-pentyl-1H-indol-3-yl)-2-(2-methoxyphenyl)-ethanone.

Some
  trade and other names:

JWH-250

(n) Mephedrone (4-methylmethcathinone).

Some
  trade and other names:

4-MMC,
  M-Cat, meow meow, miaow miaow, bounce, bubbles,

bubble
  love, mad cow, plant food, drone, and neo doves

(o) 4-Methyl-alpha-pyrrolidinobutyrophenone.

Some
  trade and other names:

MPBP

(p) Methylenedioxypyrovalerone

Some
  trade and other names:

MDPV,
  Bath salts, charge plus, cloud nine, hurricane

Charlie,
  ivory wave, ocean, red dove, scarface, sonic, white

dove,
  white lightning

(q) 5,6-Methylenedioxy-2-aminoindane

Some
  trade and other names:

MDAI

Woof-woof

(r) Naphyrone (Naphthylpyrovalerone)

Some
  trade and other names:

NRG-1

Rave

(s) Pyrovalerone (1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-pentanone)

    
(t) Catha edulis; except as provided in subdivision (u) and section 7218, all parts of the plant presently classified botanically as catha edulis, whether growing or not; the leaves and seeds of that plant; any extract from any part of that plant; and every compound, salt, derivative, mixture, or preparation of that plant or its leaves, seeds, or extracts.

Some
  trade and other names:

Khat

Qat

(u) Cathinone.

    
(v) Salvia divinorum; except as provided in subdivision (w), all parts of the plant presently classified botanically as salvia divinorum, whether growing or not; the leaves and seeds of that plant; any extract from any part of that plant; and every compound, salt, derivative, mixture, or preparation of that plant or its leaves, seeds, or extracts.

    
(w) Salvinorin A.

    
(x) Synthetic cathinones. As used in this subdivision, “synthetic cathinones” includes any material, compound, mixture, or preparation that is not otherwise listed as a controlled substance in this schedule or in schedules II through V, is not approved by the federal food and drug administration as a drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues (analogs), and salts of isomers and homologues (analogs), unless specifically excepted, whenever the existence of these salts, isomers, homologues (analogs), and salts of isomers and homologues (analogs) is possible within the specific chemical designation:

    
(i) Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at the nitrogen atom by an alkyl group, cycloalkyl group, or incorporation into a heterocyclic structure. Examples of this structural class include, but are not limited to, dimethylcathinone, ethcathinone, and alpha-pyrrolidinopropiophenone.

    
(ii) Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at the 3-position carbon with an alkyl, haloalkyl, or alkoxy group. Examples of this structural class include, but are not limited to, naphyrone.

    
(iii) Any compound containing a 2-amino-1-propanone structure with substitution at the 1-position with a monocyclic or fused polycyclic ring system and a substitution at any position of the ring system with an alkyl, haloalkyl, halogen, alkylenedioxy, or alkoxy group, whether or not further substituted at any position on the ring system to any extent. Examples of this structural class include, but are not limited to, mephedrone, methylone, and 3-fluoromethylone.

    
(2) Marihuana, including pharmaceutical-grade cannabis, is a schedule 2 controlled substance if it is manufactured, obtained, stored, dispensed, possessed, grown, or disposed of in compliance with this act and as authorized by federal authority.

    
(3) For purposes of subsection (1), "isomer" includes the optical, position, and geometric isomers.

Instrument

Definitions -- 'Industrial hemp' (subsection (f)), 'Marihuana' (subsections (h)-(i)), and 'THC' (subsection (aa))

Source

https://www.legislature.mi.gov/documents/mcl/pdf/mcl-Initiated-Law-1-of-2018.pdf

Retrieved

2026-07-02

Fingerprint

e8c0162c5008c928

333.27953 Definitions.

Sec. 3.

As used in this act:

(f) “Industrial hemp” means any of the following:

(i) A plant of the genus Cannabis, whether growing or not, with a THC concentration of 0.3% or less on a dry-weight basis.

(ii) A part of a plant of the genus Cannabis, whether growing or not, with a THC concentration of 0.3% or less on a dry-weight basis.

(iii) The seeds of a plant of the genus Cannabis with a THC concentration of 0.3% or less on a dry-weight basis.

(iv) If it has a THC concentration of 0.3% or less on a dry-weight basis, a compound, manufacture, derivative, mixture, preparation, extract, cannabinoid, acid, salt, isomer, or salt of an isomer of any of the following:

(A) A plant of the genus Cannabis.

(B) A part of a plant of the genus Cannabis.

(v) A product to which 1 of the following applies:

(A) If the product is intended for human or animal consumption, the product, in the form in which it is intended for sale to a consumer, meets both of the following requirements:

(I) Has a THC concentration of 0.3% or less on a dry-weight or per volume basis.

(II) Contains a total amount of THC that is less than or equal to the limit established by the cannabis regulatory agency under section 8(1)(n).

(B) If the product is not intended for human or animal consumption, the product meets both of the following requirements:

(I) Contains a substance listed in subparagraph (i), (ii), (iii), or (iv).

(II) Has a THC concentration of 0.3% or less on a dry-weight basis.

(h) "Marihuana" means any of the following:

(i) A plant of the genus Cannabis, whether growing or not.

(ii) A part of a plant of the genus Cannabis, whether growing or not.

(iii) The seeds of a plant of the genus Cannabis.

(iv) Marihuana concentrate.

(v) A compound, manufacture, salt, derivative, mixture, extract, acid, isomer, salt of an isomer, or preparation of any of the following:

(A) A plant of the genus Cannabis.

(B) A part of a plant of the genus Cannabis.

(C) The seeds of a plant of the genus Cannabis.

(D) Marihuana concentrate.

(vi) A marihuana-infused product.

(vii) A product with a THC concentration of more than 0.3% on a dry-weight or per volume basis in the form in which it is intended for sale to a consumer.

(viii) A product that is intended for human or animal consumption and that contains, in the form in which it is intended for sale to a consumer, a total amount of THC that is greater than the limit established by the cannabis regulatory agency under section 8(1)(n).

(i) Except for marihuana concentrate extracted from any of the following, "marihuana" does not include any of the following:

(i) The mature stalks of a plant of the genus Cannabis.

(ii) Fiber produced from the mature stalks of a plant of the genus Cannabis.

(iii) Oil or cake made from the seeds of a plant of the genus Cannabis.

(iv) A compound, manufacture, salt, derivative, mixture, or preparation of the mature stalks of a plant of the genus Cannabis.

(v) Industrial hemp.

(vi) An ingredient combined with marihuana to prepare topical or oral administrations, food, drink, or other products.

(vii) A drug for which an application filed in accordance with 21 USC 355 is approved by the Food and Drug Administration.

(aa) “THC” means any of the following:

(i) Tetrahydrocannabinolic acid.

(ii) Unless excluded by the cannabis regulatory agency under section 8(2)(c), a tetrahydrocannabinol, regardless of whether it is artificially or naturally derived.

(iii) A tetrahydrocannabinol that is a structural, optical, or geometric isomer of a tetrahydrocannabinol described in subparagraph (ii).